GIGNY vs DOCS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GIGNY · GENTING SINGAPORE LTD UNSP ADR EACH REP 50 ORD$23.86 ▲ 0.00%
DOCS · Doximity$32.51 ▼ 2.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GIGNY -4.4%
- DOCS -38.1%
Head to head
| Metric | GIGNY | DOCS |
|---|---|---|
| Price | $23.86 | $32.51 |
| Change today | ▲ 0.00% | ▼ 2.02% |
| Market cap | $5.81B | $5.80B |
| Return, 3 months | +3.9% | +26.8% |
| Return, year to date | -10.8% | -26.6% |
| Return, 1 year | -4.4% | -40.1% |
| P/E (TTM) | 23.9 | 45.2 |
| P/B | 0.9 | 6.2 |
| P/E percentile vs own 5y | – | 27th |
| Dividend yield | 6.56% | – |
| Revenue growth (YoY, latest qtr) | – | +7.3% |
| Net profit growth (YoY) | – | -54.4% |
| Gross margin | – | 88.1% |
| Operating margin | – | 29.6% |
| Net margin | – | 25.5% |
| Return on equity | – | 17.2% |
| Analyst target vs. price | – | -2.5% |
| Analyst buy share | – | 44% |
| RSI (14) | 55 | 55 |
| 30-day volatility | 14.3% | 46.8% |
| Max drawdown, 1 year | -33.6% | -73.7% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GIGNY is the largest of the group by market value.
- GIGNY has returned the most over the past year.
- GIGNY carries the lowest trailing P/E.
- GIGNY has been the calmest stock over the last 30 days.